|
|
Bradley S. Mayhew Registered Patent Agent
Admissions
Education
Bradley Mayhew is registered to practice before the U.S. Patent & Trademark Office.
His primary focus is the preparation and prosecution of patent applications
drawn to inventions in the areas of biotechnology, pharmacology and chemistry.
Brad has significant work experience in the field of Intellectual
Property. Prior to founding
Patronus Consulting,
Brad worked as a Patent Agent at the law firm of Sidley Austin Brown & Wood where he conducted
research in support of patent litigation as well as patent infringement
and freedom-to-operate opinions. Brad also worked as an Intellectual
Property Manager at Medimmune where he assessed the potential value and patentability of
inventions, coordinated with inventors and external counsel to direct patent
prosecution, and monitored competitive intellectual property developments.
In addition, Brad served for three years as a Patent Examiner at the U.S. Patent & Trademark
Office where he examined cases in the area of complex biotechnology.
Brad has extensive knowledge of subjects relevant to the biotechnology
and pharmaceutical industries. He performed and published research in the
fields of enzymology and drug metabolism as a researcher in the Department of Medicine at the
Indiana University School of Medicine. He also earned a graduate degree from the school’s
Department of Pharmacology where his studies included courses in pharmacology,
physiology, medicinal chemistry, bio-organic chemistry, biophysics, biochemistry
and physical biochemistry. Brad additionally holds an undergraduate
degree in biology with an emphasis in molecular genetics and a minor in chemistry.
Prior to graduate study, Brad worked in Japan as an editor in the
Research Planning Department of Sankyo Co., Ltd., a major Japanese pharmaceutical
company. His work involved editing and rewriting manuscripts from diverse
fields including chemistry, analytical chemistry, biochemistry, pharmacology,
toxicology and clinical medicine. The experience provided a unique insight
into the mechanisms for research and development conducted in the pharmaceutical
industry.
Prior Employment
Memberships
Publications
| ◦ |
Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, and Hall
SD
"Diltiazem Inhibition of CYP3A Activity is Due to Metabolite Intermediate
Complex Formation" Journal of Pharmacology and Experimental
Therapeutics, 1999, vol. 290, no. 3, pages 1116-1125 |
| ◦ |
Hall SD, Mayhew BS, Gorski JC, and Jones DR
"Principles of In Vitro Studies: Enzyme Kinetics, Inhibition and
Induction" in Drug-Drug Interactions: Analyzing In Vitro-In
Vivo Correlations, IBC USA, Inc., 1996 |
| ◦ |
Mayhew BS, Jones DR, Gorski JC, and Hall SD
"Non-Hyperbolic Interactions Between Substrates of Cytochrome P450
(CYP) 3A4" Midwest Cytochrome P450 Symposium, 1996 |
| ◦ |
Mayhew BS, Gorski JC, and Hall SD
"Midazolam Hydroxylation Reveals the Potential for Non-Hyperbolic
Kinetics in Cytochrome P450 (CYP) 3A4" ISSX Proceedings, 1995,
vol. 8, page 3 |
|
|
|